Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
Publication
, Journal Article
Wallentin, L; Lopes, RD; Hanna, M; Thomas, L; Hellkamp, A; Nepal, S; Hylek, EM; Al-Khatib, SM; Alexander, JH; Alings, M; Amerena, J; Ansell, J ...
Published in: Circulation
January 14, 2014
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 14, 2014
Volume
129
Issue
2
Start / End Page
e21 / e22
Location
United States
Related Subject Headings
- Warfarin
- Thromboembolism
- Stroke
- Pyridones
- Pyrazoles
- Male
- Humans
- Female
- Cardiovascular System & Hematology
- Atrial Fibrillation
Citation
APA
Chicago
ICMJE
MLA
NLM
Wallentin, L., Lopes, R. D., Hanna, M., Thomas, L., Hellkamp, A., Nepal, S., … Granger, C. B. (2014). Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation, 129(2), e21–e22. https://doi.org/10.1161/CIRCULATIONAHA.113.005709
Wallentin, Lars, Renato D. Lopes, Michael Hanna, Laine Thomas, Anne Hellkamp, Sunil Nepal, Elaine M. Hylek, et al. “Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".” Circulation 129, no. 2 (January 14, 2014): e21–22. https://doi.org/10.1161/CIRCULATIONAHA.113.005709.
Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, et al. Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation. 2014 Jan 14;129(2):e21–2.
Wallentin, Lars, et al. “Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".” Circulation, vol. 129, no. 2, Jan. 2014, pp. e21–22. Pubmed, doi:10.1161/CIRCULATIONAHA.113.005709.
Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola V-P, Held C, Horowitz J, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJV, Oh B-H, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB. Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation. 2014 Jan 14;129(2):e21–e22.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 14, 2014
Volume
129
Issue
2
Start / End Page
e21 / e22
Location
United States
Related Subject Headings
- Warfarin
- Thromboembolism
- Stroke
- Pyridones
- Pyrazoles
- Male
- Humans
- Female
- Cardiovascular System & Hematology
- Atrial Fibrillation